Zyprexa is an olanzapine tablet for adults with schizophrenia or bipolar disorder. It helps reduce psychosis and stabilise mood by affecting dopamine and serotonin signalling.
Zyprexa is an atypical antipsychotic tablet containing olanzapine. It is used in adults with schizophrenia or bipolar disorder, including manic and mixed episodes. Olanzapine acts on dopamine and serotonin signalling, helping reduce psychosis, stabilise mood, and prevent relapse.
Zyprexa tablets contain olanzapine, an atypical antipsychotic. This medicine is prescribed for schizophrenia and bipolar I disorder, where symptoms may include hallucinations, fixed false beliefs, severe agitation, racing thoughts, reduced need for sleep, or unstable mood.
Olanzapine affects several brain receptors, including dopamine D2 and serotonin 5-HT2A receptors. Dopamine is involved in motivation, perception, and salience, while serotonin influences mood, sleep, and anxiety. Balancing these pathways can reduce acute symptoms and support longer-term stability. The WHO includes antipsychotic medicines among essential treatments for psychotic disorders and bipolar illness [1].
A benefit of Zyprexa is its broad action on psychotic and mood symptoms. Weight gain and metabolic changes are the main trade-offs, so treatment includes more than simply taking a tablet.
Take Zyprexa tablets by mouth once daily at the prescribed time. Swallow the tablet whole with water, with or without food. The prescriber sets the dose and adjusts it gradually according to diagnosis, response, daytime sedation, age, liver function, and other medicines.
Common administration points include:
Abrupt discontinuation can lead to insomnia, nausea, sweating, anxiety, or return of psychiatric symptoms. A gradual reduction is often used when treatment needs to change.
Zyprexa reduces excessive dopamine activity in brain pathways linked with hallucinations, delusions, and disorganised thinking. It also blocks serotonin receptors, which may improve mood symptoms and can lower the likelihood of movement-related adverse effects seen with older antipsychotics.
Olanzapine has effects beyond sedation.
The FDA prescribing information describes olanzapine as an antipsychotic for schizophrenia and bipolar I disorder, including acute manic or mixed episodes and maintenance treatment in defined settings [2].
Antipsychotic selection depends on the diagnosis, previous response, sleep pattern, body weight, diabetes risk, movement symptoms, and the person’s ability to maintain a daily regimen.
| Treatment approach | Main clinical profile | Main limitation |
|---|---|---|
| Olanzapine | Strong option for psychosis, acute mania, agitation, and sleep disruption | Higher risk of increased appetite, weight gain, and metabolic changes |
| Risperidone | Often used for psychosis and mania; may be less sedating for some people | Can raise prolactin and cause movement symptoms at higher doses |
| Aripiprazole | Often less associated with weight gain and sedation | Can cause restlessness, insomnia, or akathisia |
Risperidone blocks dopamine and serotonin receptors but has a different receptor profile from olanzapine. Aripiprazole is a partial dopamine agonist, meaning it modulates dopamine activity rather than simply blocking it. These differences explain why one person may feel calmer and sleep better on olanzapine while another may prefer a less sedating option.
NICE guidance for bipolar disorder supports individualised antipsychotic choice, with physical health monitoring built into treatment decisions [3].
Smoking can lower olanzapine blood concentrations because tobacco smoke induces the enzyme CYP1A2. Stopping smoking can raise olanzapine exposure, while starting again can reduce it. Caffeine intake can also matter when it changes sharply, since caffeine and olanzapine share CYP1A2 metabolism.
Zyprexa is not for you if you have had a serious allergic reaction to olanzapine or any tablet component.
Drowsiness, increased appetite, dry mouth, constipation, dizziness, fatigue, and weight gain are among the most common effects of olanzapine. Some people notice stronger hunger in the evening, even when meals have not changed. This can begin early and may continue unless eating patterns are adjusted.
Weight gain deserves direct attention. Olanzapine can affect appetite, insulin sensitivity, blood sugar, and blood lipids. Regular measurement of body weight, waist circumference, blood pressure, glucose, and lipid levels helps identify changes before they become harder to reverse.
Less common but serious effects need prompt medical assessment:
Avoid driving, cycling in traffic, or operating machinery until the individual effect is clear. Alcohol can make sedation more intense. Heat exposure also needs care because olanzapine may reduce the body’s ability to regulate temperature and can contribute to dehydration.
Several avoidable patterns can make Zyprexa treatment less successful:
A frequent misconception is that antipsychotic treatment only matters during a crisis. For schizophrenia and bipolar disorder, maintenance treatment can lower relapse risk after symptoms improve. The exact duration is individual and depends on diagnosis, episode history, response, and adverse effects.
In clinical practice, doctors often value olanzapine when psychosis, severe mania, agitation, reduced sleep, and poor food intake occur together. It can settle acute symptoms well for many patients, especially when insomnia is amplifying distress and impulsivity.
The first treatment review should not focus only on whether voices, paranoia, or manic energy have reduced. Appetite, body weight, daytime alertness, blood pressure, glucose, and lipid results need equal attention. A person who feels mentally steadier but gains weight quickly may need active nutritional support, a dose review, or a different treatment approach.
Doctors also assess adherence without blame. Missing tablets because of sedation, embarrassment, travel, or feeling well again is common. Relapse prevention works best when the treatment plan fits the person’s daily life.
Zyprexa is used for schizophrenia and bipolar I disorder, including manic or mixed episodes. Olanzapine may also be part of maintenance treatment to reduce the chance of future mood episodes in selected patients. The FDA prescribing information, revised in 2022, lists these psychiatric indications for olanzapine tablets. Treatment goals differ between acute symptom control and relapse prevention.
Sleep, agitation, and severe anxiety may improve earlier than hallucinations, delusions, or mood stability. Thought organisation and recovery from mania often need sustained daily treatment and clinical follow-up. The WHO’s 2023 mental health guidance describes psychosis care as ongoing treatment rather than a single-dose intervention. Early sedation should not be used as the sole marker of therapeutic response.
Yes. Increased appetite and weight gain are well-recognised effects of olanzapine. The risk is one reason clinicians monitor weight, blood glucose, and blood lipids during treatment. NICE guidance updated in 2023 supports physical health monitoring for people treated with antipsychotics. Dietary planning is easier when appetite changes are addressed early.
Alcohol can increase sedation, dizziness, slowed reaction time, and impaired coordination from olanzapine. It can also worsen sleep quality and destabilise mood in bipolar disorder. FDA safety information from 2022 advises caution with other central nervous system depressants. Avoiding alcohol is the safer choice during treatment.
Sudden discontinuation may cause insomnia, nausea, sweating, anxiety, agitation, and return of psychiatric symptoms. A gradual dose reduction is often preferred when a treatment change is clinically appropriate. The EMA product information for olanzapine, published in 2024, describes withdrawal symptoms after abrupt stopping. A planned taper allows symptoms and adverse effects to be monitored.
Yes. Tobacco smoke can increase CYP1A2 enzyme activity, which may lower olanzapine concentrations. If smoking habits change, the prescribed dose may need reassessment because the medicine’s effect can change too. A 2020 American Psychiatric Association schizophrenia guideline recognises smoking status as a relevant medication-management factor. Nicotine replacement itself does not have the same enzyme-inducing effect as tobacco smoke.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
The first days made me very sleepy, so my prescriber moved my tablet to the evening. My thoughts slowed down and I stopped sleeping only two or three hours a night. I had to plan snacks because my appetite increased a lot.
I had taken it after a manic episode and felt more settled within the first part of treatment. The difficult part was daytime tiredness at work. Keeping the dose at the same evening time made a noticeable difference.
It helped with paranoia and I was sleeping normally again. I gained weight faster than I expected, which was frustrating. My clinician arranged blood tests and we worked on meals rather than ignoring it.
I missed doses when travelling and my sleep became irregular again. Once I returned to a fixed routine, things were more stable. Dry mouth was annoying at first but became easier to manage.
